NCT01163357 2025-03-26Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple MyelomaCity of Hope Medical CenterPhase 1 Completed18 enrolled